Trial Profile
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of LX4211 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Sotagliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Lexicon Pharmaceuticals
- 19 May 2015 Efficacy results correlated with urine sodium:creatinine ratio presented at the 30th Annual Scientific Meeting of the American Society of Hypertension.
- 26 Sep 2013 Tolerability results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 24 Sep 2013 BP results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.